Last reviewed · How we verify

aspirin placebo (ASA Pbo)

Abbott · Phase 3 active Small molecule

aspirin placebo (ASA Pbo) is a Nonsteroidal anti-inflammatory drug (NSAID) Small molecule drug developed by Abbott. It is currently in Phase 3 development for Prevention of cardiovascular disease and stroke, Treatment of pain and inflammation. Also known as: placebo.

Aspirin works by inhibiting the enzyme cyclooxygenase (COX), which is involved in the production of prostaglandins and thromboxanes.

Aspirin works by inhibiting the enzyme cyclooxygenase (COX), which is involved in the production of prostaglandins and thromboxanes. Used for Prevention of cardiovascular disease and stroke, Treatment of pain and inflammation.

At a glance

Generic nameaspirin placebo (ASA Pbo)
Also known asplacebo
SponsorAbbott
Drug classNonsteroidal anti-inflammatory drug (NSAID)
TargetCOX-1 and COX-2
ModalitySmall molecule
Therapeutic areaCardiovascular
PhasePhase 3

Mechanism of action

This inhibition leads to a decrease in platelet aggregation and inflammation, which can help to prevent blood clots and reduce pain and inflammation. Aspirin is a non-selective COX inhibitor, meaning it affects both COX-1 and COX-2 enzymes.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about aspirin placebo (ASA Pbo)

What is aspirin placebo (ASA Pbo)?

aspirin placebo (ASA Pbo) is a Nonsteroidal anti-inflammatory drug (NSAID) drug developed by Abbott, indicated for Prevention of cardiovascular disease and stroke, Treatment of pain and inflammation.

How does aspirin placebo (ASA Pbo) work?

Aspirin works by inhibiting the enzyme cyclooxygenase (COX), which is involved in the production of prostaglandins and thromboxanes.

What is aspirin placebo (ASA Pbo) used for?

aspirin placebo (ASA Pbo) is indicated for Prevention of cardiovascular disease and stroke, Treatment of pain and inflammation.

Who makes aspirin placebo (ASA Pbo)?

aspirin placebo (ASA Pbo) is developed by Abbott (see full Abbott pipeline at /company/abbott).

Is aspirin placebo (ASA Pbo) also known as anything else?

aspirin placebo (ASA Pbo) is also known as placebo.

What drug class is aspirin placebo (ASA Pbo) in?

aspirin placebo (ASA Pbo) belongs to the Nonsteroidal anti-inflammatory drug (NSAID) class. See all Nonsteroidal anti-inflammatory drug (NSAID) drugs at /class/nonsteroidal-anti-inflammatory-drug-nsaid.

What development phase is aspirin placebo (ASA Pbo) in?

aspirin placebo (ASA Pbo) is in Phase 3.

What are the side effects of aspirin placebo (ASA Pbo)?

Common side effects of aspirin placebo (ASA Pbo) include Gastrointestinal upset, Bleeding, Allergic reactions.

What does aspirin placebo (ASA Pbo) target?

aspirin placebo (ASA Pbo) targets COX-1 and COX-2 and is a Nonsteroidal anti-inflammatory drug (NSAID).

Related